Dr Rotherham was responsible for developing and growing ClinPhone plc, one of Nottingham's and Europe's most successful clinical technology businesses.
As co-founder and managing director of ClinPhone, Dr Rotherham led the company from a two-person start-up in 1993 to a 500-person global venture that was listed on the London Stock Exchange in 2006. Dr Rotherham left the business after bringing through a management team to run the business subsequent to going public.
Prior to co-founding ClinPhone, Dr Rotherham worked in the pharmaceutical industry on medicine development for Boots Pharmaceuticals. His prior qualification in medicine and training as a hospital physician will undoubtedly be beneficial to PRECOS as it looks to establish its range of innovative services within the global healthcare industry. Dr Rotherham brings a wealth of experience in growing businesses providing services to drug development companies.
Dr Rotherham said: "This places the company in an optimal position to deliver specialist services, backed by significant industry expertise and cutting-edge technology, to help both pharmaceutical and biotechnology companies develop new anti-cancer drugs.
"PRECOS occupies a niche in global pre-clinical R&D working with unique patient-relevant models closely reflecting the patient situation. Tumour development can be monitored in real-time, allowing companies to concentrate efforts on those compounds most likely to have a therapeutic effect in patients with cancer."
Professor Sue Watson, Chief Scientific Officer of PRECOS, said: "We are delighted to welcome Neil as chairman of the PRECOS board. Neil's unparalleled experience and business acumen will be crucial in directing the company's growth. This appointment reinforces the ambition and potential of PRECOS to exploit the growing cancer therapy market. We are extremely excited to develop our expertise in cancer drug development into medicines with real patient benefits."
PRECOS, an acronym of Pre-Clinical Oncology Services, was officially launched as a specialist business unit of the University of Nottingham (UK) in 2004. PRECOS evolved from the research expertise of the Division of Pre-clinical Oncology (formerly Academic Unit of Cancer Studies), which had successful collaborations with pharmaceutical and biotech companies in the UK, EU, US and Japan for over a decade.
PRECOS Ltd
